At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 10, 2026 at 16:11 ET
Royalty Pharma plc has filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting. The filing is routine and does not indicate any activist campaign or contested vote. It is a standard annual disclosure required by the SEC.
- Company: Royalty Pharma plc (RPRX)
- Filing Type: DEFA14A (Definitive Proxy Statement)
- Purpose: Routine annual shareholder meeting
- No activist involvement or contested votes
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access